Clinical Trial Update: One Week Comparison Study of PTH and PTHrP Infusions [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating infusions of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) for osteoporosis and related endocrine bone co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endocrine Bone Disease
• Hypercalcemia of Malignancy
• Hyperparathyroidism
• Osteoporosis

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)
• parathyroid hormone-related peptide (parathyroid hormone-related peptide)

Snippet

Sponsor: University of Pittsburgh | Conditions: Osteoporosis, Hypercalcemia of Malignancy | Phase 1 | Status: WITHDRAWN